GlassScriptPhysician profile
Preethi Rajendran
NPI 1740637719
$1,643.96
in general payments reported to CMS, 2019-2025
18 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $69.02 · 2020: $77.02 · 2021: $389 · 2022: $128 · 2023: $506 · 2024: $330 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $981.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $981.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aspira Women'S Health INC | $270.07 | 2021-2023 | Ova1 |
| Astellas Pharma US INC | $188.00 | 2023-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $177.13 | 2019-2023 | |
| Coopersurgical, INC. | $163.93 | 2019-2025 | Paragard T 380a, Paragard T 380a, Summit Doppler |
| Mayne Pharma Commercial LLC | $153.24 | 2023-2025 | |
| Caldera Medical, INC | $124.36 | 2023 | Desara |
| Pfizer INC. | $110.20 | 2022-2024 | |
| Exeltis, USA INC. | $71.49 | 2023-2024 | Slynd |
| Therapeuticsmd, INC. | $70.18 | 2020-2022 | |
| Myovant Sciences INC. | $67.32 | 2021-2022 | |
| Evofem Biosciences, INC. | $60.15 | 2021-2025 | Phexxi, Solosec, Phexx |
| Sage Therapeutics, LLC | $47.61 | 2024-2025 | Zurzuvae |
| Shield Therapeutics INC | $31.69 | 2024 | |
| Baxter Healthcare | $27.50 | 2020 | |
| Exact Sciences Corporation | $24.13 | 2023 | Cologuard Collection Kit |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.29 | 2023 | |
| Daiichi Sankyo INC. | $18.84 | 2025 | Injectafer |
| Merck Sharp & Dohme LLC | $17.83 | 2025 | Gardasil 9 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Preethi Rajendran listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.